In our upcoming webinar, we delve into the role of Gross-to-Net (GtN) investments in driving profitability and revenue growth for global pharmaceutical companies.
While optimizing launch pricing is often the focus for pharmaceutical market access professionals, our experience globally indicates that GtN optimization is frequently overlooked leading to missed opportunities and revenue left on the table.
During this webinar, we dive into the role of GtN excellence in driving profitability and revenue growth for global pharmaceutical companies. Participants can be expected to learn:
- Common GtN pitfalls: Identify typical GtN pitfalls and areas leading to revenue leakage.
- Methodological approaches: Learn analytical approaches to identify and optimize GtN opportunities, allowing you to capitalize on untapped revenue streams.
- Best-in-class GtN concepts: Understand the logic and structures of best-in-class GtN used by global market leaders.
- Case studies: Explore past project experiences through real-world case studies illustrating the potential revenue impact achievable through GtN optimization.
By attending this webinar, participants will acquire a comprehensive understanding into the vital role GtN investments play in optimizing revenue and profitability growth. You will learn how to conduct effective GtN diagnostics to uncover inefficiencies in your GtN strategy and explore potential solutions for revenue maximization through GtN investments.
Thursday; March 7
4:00 p.m. SGT/ 9:00 a.m. CET/ 12:00 p.m. GST
Join us for this enlightening webinar and unlock the untapped revenue potential in your Pharma organization by staying at the forefront of commercial strategy.
This event is free-of-charge.